proglumetacin has been researched along with Plica Syndrome in 2 studies
proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardito, S | 1 |
| Leonardi, W | 1 |
| Longo, G | 1 |
| Stargardt, M | 1 |
| Kasper, E | 1 |
1 trial available for proglumetacin and Plica Syndrome
| Article | Year |
|---|---|
[Treatment of secondary synovitis. Double blind study of proglumetacin versus indomethacin].
Topics: Adult; Aged; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; Indoleacetic Acids; Indo | 1985 |
1 other study available for proglumetacin and Plica Syndrome
| Article | Year |
|---|---|
[Proglumetacin: a simple and practical anti-inflammatory agent for the treatment of hospitalized orthopedic patients].
Topics: Adolescent; Adult; Aged; Arthritis; Bursitis; Child; Drug Evaluation; Drug Tolerance; Female; Humans | 1983 |